Bivalirudin Plus Prasugrel vs Abciximab Plus Clopidogrel. Optimizing Ischemic Protection and Bleeding Risk in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Latest Information Update: 09 Feb 2024
At a glance
- Drugs Bivalirudin (Primary) ; Prasugrel (Primary) ; Abciximab; Clopidogrel
- Indications Coronary thrombosis
- Focus Adverse reactions
Most Recent Events
- 29 Jul 2010 New trial record